The importance of understanding what is PRGF and what is not.
J Shoulder and Elbow Surgery 2011, 20, e23-e24
Autores
Anitua E, Sánchez M, Orive G.
Autores
Anitua E, Sánchez M, Prado R, Orive G.
The P makes the difference in plasma rich in growth factors (PRGF) technology.
Platelets (In press 2011)
Autores
Anitua E, Alkhraisat MH, Orive G.
Perspectives and challenges in regenerative medicine using Plasma Rich in Growth Factors.
Journal of Controlled Release (In Press 2011)
Autores
Guerra I, Morais Branco F, Vasconcelos M, Afonso A, Figueiral H, Zita R.
Evaluation of implant osseointegration with different regeneration techniques in the treatment of bone defects around implants: an experimental study in a rabbit model.
Clin Oral Implants Res. 2010
Autores
Gallo I, Sáenz A, Artiñano E, Esquide J.
Autologous platelet-rich plasma: effect on sternal healing in the sheep model.
Interact Cardiovasc Thorac Surg. 2010; 11(3):223-5.
Autores
Sanchéz M, Anitua E, Andia I.
Poor standardization in platelet-rich therapies hampers advancement.
Arthroscopy, 2010, 26 (6), 725-6
Autores
Orive G, Ali OA, Anitua E, Pedraz JL, Emerich DF.
Novel Biomaterial-based technologies for brain anti-cancer therapeutics.
Biochim Biophys Acta. 2010; 1806(1):96-107
Autores
López-Jornet P, Camacho-Alonso F, Molina-Miñano F, Vicente-Ortega V.
Effects or plasma rich in growth factor on wound healing of the tongue. Experimental study in rabbits.
Med Oral Patol Oral Cir Bucal 2009; 14 (9): 425-428.
Autores
Harguindey S, Arranz JL, L. Wahl M, Orive G, J. Reshkin S.
Proton transport inhibitors (pti) as potentially selective anticancer drugs.
Anticancer Research 2009; 29 (6):2127-36
Autores
Harguindey S, Orive G, Cacabelos R, Hevia EM, Otazu RD, Arranz JL, Anitua E
An integral approach to the etiopathogenesis of human neurodegenerative diseases (hndds) and cancer. Possible therapeutic consequences within the frame of the trophic factor withdrawal syndrome (TFWS).
Neuropsychiatry Dis. Treatment. 2008; 4:1073-1084.
Autores
Harguindey S, Reshkin S, Orive G, Arranz, JL, Anitua E.
Growth and trophic factors, pH and the Na/H exchanger in Alzheimer´s disease, other neurodegenerative diseases and cancer: New therapeutic possibilities and potential dangers.
Curr Alzheimer Dis 2007;4:53-65.
Autores
Harguindey S, Orive G, et al.
The role of pH dynamics and the Na/H antiporter in the ethiopathogenesis and treatment of cancer. Two faces of the same coin-one single nature.
BBA Cancer Rev 2005;1756:1-24.
Autores
Orive G., Gascón AR, Hernández RM, Pedraz JL.
The search for new B-cell sources.
Trends Biotechnology 2004; 22: 612-613
Autores
Orive G., Hernández RM, Gascón AR, Domínguez-Gil A, Pedraz JL
New approaches in the delivery of biopharmaceuticals
Trends Pharmacological Sci 2004; 25: 382-387
Autores
Orive G., Reshkin S.J., Harguindey S., Pedraz J.L.
Hydrogen ion dynamics and the Na+/H+ exchanger in cancer angiogenesis and antiangiogenesis
British J Cancer 2003; 89: 1395-1399
Autores
Orive G., Hernández R., Gascón A.R., Igartua M., Pedraz J.L.
A glimmer of hope for diabetics?
Trends Biotechnology 2003; 21 (7): 289-290.
Autores
Orive G., Hernández RM, Gascón AR, Igartua M, Pedraz JL
Controversies over stem cell research.
Trends Biotechnology 2003; 21: 109-112.
Autores
Orive G, Hernández R, Gascón A.R., Calafiore R, Chang T.M.S., De Vos P, Hortelano G, Hunkeler D, Lacik I, Shapiro A.M.J., Pedraz J.L.
Cell microencapsulation: promise and progress.
Nature Medicine 2003; 9: 104-107
Autores
Murua A, Orive G, Hernández RM, Pedraz JL
Emerging technologies in the delivery of erythropoietin for therapeutics.
[ Ver Abstract ]Med Res Rev. 2011; 31(2):284-309